Cargando…

Comparison of Clinical Trajectories before Initiation of Renal Replacement Therapy between Diabetic Nephropathy and Nephrosclerosis on the KDIGO Guidelines Heat Map

This study investigated differences between the clinical trajectories of diabetic nephropathy and nephrosclerosis using the Kidney Disease: Improving Global Outcomes (KDIGO) heat map and the clinical characteristics between the two diseases at RRT initiation. This single-center, retrospective study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abe, Masanori, Okada, Kazuyoshi, Maruyama, Noriaki, Takashima, Hiroyuki, Oikawa, Osamu, Soma, Masayoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709677/ https://www.ncbi.nlm.nih.gov/pubmed/26839894 http://dx.doi.org/10.1155/2016/5374746

Ejemplares similares

T/L-type calcium channel blocker reduces the composite ranking of relative risk according to new KDIGO guidelines in patients with chronic kidney disease
por: Abe, Masanori, et al.
Publicado: (2013)

Randomized Controlled Trial of Darbepoetin α Versus Continuous Erythropoietin Receptor Activator Injected Subcutaneously Once Every Four Weeks in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage
por: Furukawa, Tetsuya, et al.
Publicado: (2015)

Comparison of Sustained Hemodiafiltration with Acetate-Free Dialysate and Continuous Venovenous Hemodiafiltration for the Treatment of Critically Ill Patients with Acute Kidney Injury
por: Abe, Masanori, et al.
Publicado: (2011)

From KDIGO 2012 towards KDIGO 2021 in idiopathic membranous nephropathy guidelines: what has changed over the last 10 years?
por: Stai, Stamatia, et al.
Publicado: (2022)

Oral Zinc Supplementation Reduces the Erythropoietin Responsiveness Index in Patients on Hemodialysis
por: Kobayashi, Hiroki, et al.
Publicado: (2015)

Mineral Metabolic Abnormalities and Mortality in Dialysis Patients
por: Abe, Masanori, et al.
Publicado: (2013)

Effects of Levocarnitine on Brachial-Ankle Pulse Wave Velocity in Hemodialysis Patients: A Randomized Controlled Trial
por: Higuchi, Terumi, et al.
Publicado: (2014)

Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis
por: Momoki, Kumiko, et al.
Publicado: (2017)

Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race
por: Hughson, Michael D., et al.
Publicado: (2014)

CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018)

KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors
por: Lentine, Krista L., et al.
Publicado: (2017)

KDIGO Board Members
Publicado: (2012)

Adolescent-onset TAFRO Syndrome with Malignant Nephrosclerosis-like Lesions
por: Nakayama, Yuki, et al.
Publicado: (2022)

Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients
por: González, Luz M., et al.
Publicado: (2023)

Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD
por: Mann, Johannes F. E., et al.
Publicado: (2021)

Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy
por: Nordbø, Ole Petter, et al.
Publicado: (2023)

Statin use before and after the KDIGO Lipids in chronic kidney disease guideline: A population‐based interrupted time series analysis
por: Kampmann, Jan D., et al.
Publicado: (2022)

Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis
por: Kobayashi, Hiroki, et al.
Publicado: (2016)

Investigation into the underlying molecular mechanisms of hypertensive nephrosclerosis using bioinformatics analyses
por: Liu, Tianlong, et al.
Publicado: (2018)

Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study
por: Kurumatani, Hajimu, et al.
Publicado: (2021)

Multiple imputation is better than KDIGO guidelines for estimating unknown baseline renal function
por: Jamme, Matthieu, et al.
Publicado: (2016)

Bone Morphogenetic Protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis
por: Bramlage, Carsten P, et al.
Publicado: (2010)

Effect of Intensive Blood Pressure Control on Cardiovascular Remodeling in Hypertensive Patients with Nephrosclerosis
por: Randall, Otelio, et al.
Publicado: (2013)

Recovery from AKI by KDIGO criteria
por: Schrijvers, D, et al.
Publicado: (2014)

The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologists
por: Barbour, Sean, et al.
Publicado: (2014)

Erratum to: Multiple imputation is better than KDIGO guidelines for estimating unknown baseline renal function
por: Jamme, Matthieu, et al.
Publicado: (2016)

Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal
por: Rojas-Rivera, Jorge Enrique, et al.
Publicado: (2019)

Clinical Phenotypes and Long-term Prognosis in White Patients With Biopsy-Verified Hypertensive Nephrosclerosis
por: Øvrehus, Marius A., et al.
Publicado: (2019)

Genetic Variants in PGE2 Receptors Modulate the Risk of Nephrosclerosis and Clinical Outcomes in These Patients
por: González, Luz María, et al.
Publicado: (2021)

Diagnostic Workup for Disorders of Bone and Mineral Metabolism in Patients with Chronic Kidney Disease in the Era of KDIGO Guidelines
por: Morrone, Luigi Francesco, et al.
Publicado: (2011)

The KDIGO acute kidney injury guidelines for cardiac surgery patients in critical care: a validation study
por: Howitt, Samuel H., et al.
Publicado: (2018)

Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia
por: Tomáš, Šálek, et al.
Publicado: (2019)

Evaluating the feasibility of the KDIGO CKD referral recommendations
por: Singh, Karandeep, et al.
Publicado: (2017)

Serum Potassium Predicts Time to Blood Pressure Response Among African-Americans with Hypertensive Nephrosclerosis
por: Bhalla, Meeta, et al.
Publicado: (2012)

Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis
por: Sumida, Keiichi, et al.
Publicado: (2016)

Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy
por: Gutsol, Alex A., et al.
Publicado: (2022)

Tag-SNPs in Phospholipase-Related Genes Modify the Susceptibility to Nephrosclerosis and its Associated Cardiovascular Risk
por: González, Luz M., et al.
Publicado: (2022)

Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis
por: Fanelli, Camilla, et al.
Publicado: (2023)

KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
Publicado: (2018)

Corrigendum to: Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia
por: Šálek, Tomáš, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4o75pp4bq4hko425cgrg9pq99g